Concepedia

Publication | Closed Access

ENDURANCE-3: safety and efficacy of glecaprevir/pibrentasvir compared to sofosbuvir plus daclatasvir in treatment-naïve HCV genotype 3-infected patients without cirrhosis

DOI

39

Citations

0

References

2017

Year

Graham R. Foster, Edward Gane, Armen Asatryan, Tarik Asselah, P. Ruane, Stanislas Pol, F. Poordad, Catherine Stedman, Gregory J. Dore, S. Roberts,
Journal of Hepatology

No additional data available for this publication yet. Check back later!